Accelus Appoints Chris McKee as Vice President of Regulatory & Quality

New Appointment Strengthens Company’s Leadership in Regulatory Compliance and Quality Management

PALM BEACH GARDENS, Fla., May 16, 2024 Accelus, a privately held medical technology company committed to becoming the global market leader in expandable spinal implant technologies, today announced the appointment of Chris McKee as Vice President of Regulatory and Quality. With more than 18 years of experience in the medical device industry, McKee’s expertise will strengthen Accelus’s commitment to global market expansion, quality assurance and regulatory compliance.

“Chris’s deep understanding of regulatory affairs and unwavering commitment to quality align perfectly with Accelus’s mission to set new standards in spine surgery through our Adaptive Geometry™ technologies,” said Kevin McGann, President and Chief Executive Officer of Accelus. “His leadership will be crucial as we continue to innovate and expand our market presence, ensuring that our products not only meet but exceed industry standards.”

In his new role, McKee will oversee all aspects of regulatory and compliance functions at Accelus. He will guide the company’s research and development efforts to align with regulatory requirements, streamline development processes and ensure ongoing compliance to prevent market disruptions. Additionally, McKee’s expertise will be instrumental in managing risks, maintaining business continuity and driving the company’s quality management initiatives.

“I am excited to join Accelus and contribute to a culture that prioritizes safety, efficacy, and compliance,” said McKee. “Accelus’s dedication to innovation and improving patient outcomes aligns perfectly with my vision of enhancing healthcare through regulatory excellence. I look forward to working with the team to continue advancing our pioneering technologies and expanding our impact in the spinal surgery field.”

McKee brings a wealth of experience from his previous roles at Medtronic Spine and Biologics and ZimVie Dental, where he managed global product registrations, quality management system (QMS) compliance and company audits. Most recently, he was responsible for transitioning ZimVie Dental’s product portfolios to EU MDR certification and compliance. His leadership in quality and regulatory consulting, combined with his direct experience with EU MDR compliance, positions him as a key asset to the Accelus leadership team.

About Accelus

Accelus, a worldwide leader in expandable spinal implant technology, is dedicated to enhancing surgical procedures and patient outcomes through innovative spinal solutions. The company’s commitment to excellence is evident in its advanced Adaptive Geometry™ technologies specifically designed for transforaminal lumbar interbody fusion (TLIF), posterior lumbar interbody fusion (PLIF), endoscopic-assisted, percutaneous and lateral spine surgeries. For more information on Accelus and its innovative product portfolio, please visit

# # #

Chris McKee, Accelus Vice President of Regulatory and Quality